Results 281 to 290 of about 6,940,670 (314)

Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report

Chinese Journal of Lung Cancer
Editorial Office of Chinese Journal of Lung Cancer
doaj   +1 more source

HLA-I genotype landscape in lung cancer and its prognosis value in Chinese small cell lung cancer. [PDF]

Sci Rep
Zhao J, Dong B, Wang Z, Wang B, Yan C, Li X, Guo Y, Du Y.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2022
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment ...
D. Ettinger, D. Wood, D. Aisner, W. Akerley, J. Bauman, Ankit Bharat, D. Bruno, Joe Y. Chang, L. Chirieac, T. D’amico, M. Decamp, T. Dilling, J. Dowell, S. Gettinger, T. Grotz, M. Gubens, A. Hegde, R. Lackner, M. Lanuti, Jules Lin, B. Loo, C. Lovly, F. Maldonado, E. Massarelli, D. Morgensztern, T. Ng, G. Otterson, J. Pacheco, S. Patel, Gregory Riely, J. Riess, S. Schild, T. Shapiro, Aditi P. Singh, J. Stevenson, A. Tam, T. Tanvetyanon, J. Yanagawa, Stephen C. Yang, E. Yau, K. Gregory, M. Hughes   +41 more
semanticscholar   +1 more source

Lung cancer statistics, 2023

Cancer
Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population‐based data from the ...
Tyler B Kratzer, Priti Bandi, Neal D Freedman, Robert A. Smith, William D Travis, A. Jemal, R. Siegel   +6 more
semanticscholar   +1 more source